- Report
- October 2024
- 182 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- May 2024
- 150 Pages
Global
From €5649EUR$5,950USD£4,765GBP
- Report
- August 2024
- 147 Pages
Global
From €2847EUR$2,999USD£2,402GBP
- Report
- March 2025
- 193 Pages
Global
From €4699EUR$4,950USD£3,964GBP
- Report
- August 2024
- 175 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- July 2024
- 180 Pages
Global
From €2373EUR$2,500USD£2,002GBP
- Report
- July 2024
- 100 Pages
Global
From €3560EUR$3,750USD£3,003GBP
- Report
- November 2024
- 180 Pages
Asia Pacific
From €4742EUR$4,995USD£4,000GBP
- Report
- November 2024
- 144 Pages
North America
From €4742EUR$4,995USD£4,000GBP
- Report
- November 2024
- 187 Pages
Europe
From €4742EUR$4,995USD£4,000GBP
- Report
- October 2024
- 76 Pages
United States
From €4742EUR$4,995USD£4,000GBP
- Report
- July 2024
- 153 Pages
Global
From €4035EUR$4,250USD£3,403GBP
- Report
- September 2024
- 299 Pages
Global
From €4699EUR$4,950USD£3,964GBP
- Report
- October 2024
- 182 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- October 2024
- 193 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- October 2024
- 198 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- October 2024
- 189 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- October 2024
- 186 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- August 2024
- 150 Pages
Global
From €5649EUR$5,950USD£4,765GBP
- Report
- August 2024
- 100 Pages
Global
From €5649EUR$5,950USD£4,765GBP

Orthobiologics is a field of biotechnology that focuses on the development of products and treatments to improve musculoskeletal health. It includes the use of biological materials such as stem cells, growth factors, and proteins to repair, regenerate, and replace damaged or diseased tissues. Orthobiologics is used to treat a variety of musculoskeletal conditions, including fractures, tendon and ligament injuries, and degenerative joint diseases. It is also used to improve the healing of bone and soft tissue after surgery.
Orthobiologics is a rapidly growing field, with new products and treatments being developed to improve patient outcomes. It is becoming increasingly important in the treatment of musculoskeletal conditions, as it offers a more natural and less invasive approach than traditional treatments.
Some companies in the Orthobiologics market include Acelity, AlloSource, Arthrex, Bioventus, DePuy Synthes, Exactech, Integra LifeSciences, Medtronic, MiMedx, Orthofix, and Stryker. Show Less Read more